Holen Sie sich die Stockscreener-App
1.85
3.35%
0.06
Schlusskurs vom Vortag:
$1.79
Offen:
$1.8
24-Stunden-Volumen:
251.84K
Relative Volume:
0.51
Marktkapitalisierung:
$151.32M
Einnahmen:
$25.14M
Nettoeinkommen (Verlust:
$-21.57M
KGV:
-6.8519
EPS:
-0.27
Netto-Cashflow:
$-12.23M
1W Leistung:
+11.45%
1M Leistung:
-5.13%
6M Leistung:
-2.63%
1J Leistung:
-28.29%
1-Tages-Spanne:
$1.785
$1.855
1-Wochen-Bereich:
$1.58
$1.855
52-Wochen-Spanne:
$1.54
$2.7155
Stereotaxis Inc Stock (STXS) Company Profile
Firmenname
Stereotaxis Inc
Sektor
Telefon
314-678-6100
Adresse
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Vergleichen Sie STXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
1.85 | 151.32M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
482.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
198.71 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.54 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
212.91 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.51 | 15.75B | 3.90B | 392.30M | 288.10M | 1.95 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-10 | Eingeleitet | ROTH MKM | Buy |
| 2022-07-12 | Eingeleitet | Aegis Capital | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2022-01-05 | Eingeleitet | Craig Hallum | Buy |
| 2022-01-05 | Eingeleitet | Loop Capital | Buy |
| 2021-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-09-08 | Eingeleitet | Northland Capital | Outperform |
| 2020-04-09 | Eingeleitet | Cowen | Outperform |
| 2020-04-07 | Eingeleitet | Lake Street | Buy |
Alle ansehen
Stereotaxis Inc Aktie (STXS) Neueste Nachrichten
Raymond James Financial Inc. Purchases New Shares in Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World
Stereotaxis stock hits 52-week low at $1.65 amid market challenges - Investing.com Australia
Stereotaxis stock hits 52-week low at $1.65 amid market challenges By Investing.com - Investing.com South Africa
Charles Schwab Investment Management Inc. Has $349,000 Holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World
3 Promising Surgical Robotics Stocks to Keep an Eye on in 2025 - MSN
Bank of New York Mellon Corp Has $440,000 Holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS) - Defense World
Nvidia’s Support Boosts Stereotaxis (STXS) in Advancing Robotic Surgery - MSN
Stereotaxis Jumps 15% on NVIDIA's AI-Driven Collaboration: Is It a Buy Now? - MSN
What's Going On With Stereotaxis Shares Wednesday?Stereotaxis (AMEX:STXS) - Benzinga
Stereotaxis stock holds $5 target, reiterates buy at TD Cowen By Investing.com - Investing.com Canada
Stereotaxis gains support from NVIDIA for AI robotics - Investing.com
Stereotaxis Announces Acceptance into NVIDIA Connect Program and Highlights at NVIDIA GTC Conference - Nasdaq
Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program - GlobeNewswire
Q4 Rundown: Gates Industrial Corporation (NYSE:GTES) Vs Other Engineered Components and Systems Stocks - The Globe and Mail
Stereotaxis Inc. (STXS) reports earnings - Quartz
Stereotaxis director Isaac Paul acquires $68,780 in common stock By Investing.com - Investing.com South Africa
Director Makes Bold Move with Major Stereotaxis Stock Purchase - TipRanks
Stereotaxis director Isaac Paul acquires $68,780 in common stock - Investing.com Australia
Stereotaxis director Paul Isaac acquires $44,836 in common stock By Investing.com - Investing.com Canada
Stereotaxis director Paul Isaac acquires $44,836 in common stock - Investing.com Australia
Stereotaxis to Present at 37th Annual Roth Conference - GlobeNewswire
Stereotaxis: Buy Rating Affirmed on Strong Financials and Promising Growth Outlook - TipRanks
Stereotaxis Stock Slides Despite MAGiC Sweep Catheter FDA Submission - Yahoo Finance
Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn (NYSE:STXS) - Seeking Alpha
Q1 Earnings Estimate for Stereotaxis Issued By Roth Capital - Defense World
Stereotaxis, Inc. (AMEX:STXS) Q4 2024 Earnings Call Transcript - MSN
Stereotaxis submits catheter pair for FDA clearance - Robot Report
STXS Stock Tumbles Despite EMAGIN Catheter Submission for Approval - MSN
Stereotaxis sees double digit revenue growth for FY25 - Yahoo Finance
Stereotaxis submits EMAGIN catheter for regulatory clearance - Yahoo Finance
Stereotaxis announces FDA regulatory submission for MAGiC Sweep catheter - Yahoo Finance
Stereotaxis Inc (STXS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance
Stereotaxis Inc (STXS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... By GuruFocus - Investing.com Canada
Stereotaxis Earnings Call: Growth Amid Challenges - TipRanks
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates - MSN
Stereotaxis earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Stereotaxis Q4 2024 misses forecasts, stock dips By Investing.com - Investing.com Canada
Stereotaxis seeks FDA nod for robotic catheter system By Investing.com - Investing.com Canada
Stereotaxis seeks FDA nod for robotic catheter - Investing.com India
Stereotaxis seeks FDA nod for robotic catheter system - Investing.com India
Stereotaxis seeks FDA nod for robotic catheter By Investing.com - Investing.com South Africa
Finanzdaten der Stereotaxis Inc-Aktie (STXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
3.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):